Thu.May 16, 2024

article thumbnail

The only tribal medical school in the U.S. graduates its first Native American doctors

STAT

There are so few Indigenous physicians in the United States — just 0.3% of doctors — that their numbers barely show up in charts and graphs depicting the diversity of the medical workforce. But as of Thursday, there will be at least nine more. Thursday is graduation day for the first class of the nation’s only tribally affiliated medical school, the Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation.

article thumbnail

Investors put $400M into biotech licensing obesity drugs from China

PharmaVoice

The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

In military medicine, study shows rank and race affect care

STAT

Higher ranking military officers receive more resources and better care than low ranking military officers, according to an analysis of 1.5 million military ER visits published Thursday in the journal Science. The study also showed that white physicians expended less effort on Black patients, even when rank was taken into account: Higher ranking Black officers received care from white physicians that was similar to that received by lower ranking white officers.

362
362
article thumbnail

Big Pharma leaders juggle pricing and access as IRA and supply constraints loom large

PharmaVoice

Execs from J&J, Novartis, Novo Nordisk and AbbVie sound off on the Inflation Reduction Act, supply issues and launch preparations in a tricky environment.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: As childhood asthma worsens, insurers restrict access to an essential medication

STAT

As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having to go without basic medications to control their child’s asthma. At least seven children have died due to uncontrolled asthma this year in the Philadelphia region, a dramatic increase from prior years.

Inpatient 358
article thumbnail

Investors put $400M into biotech licensing obesity drugs from China

BioPharma Dive

The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.

142
142

More Trending

article thumbnail

NPA hands DHSC giant invoice for '£108m monthly shortfall'

The Pharmacist

National Pharmacy Association (NPA) leaders have delivered a giant invoice for the £108m they say is owed to the sector for dispensing at a loss over the last month. And pharmacy owners can generate their own individual invoice using a new tool launched by the NPA, which indicates the funding shortfall for each pharmacy based […] The post NPA hands DHSC giant invoice for '£108m monthly shortfall' appeared first on The Pharmacist.

121
121
article thumbnail

Opinion: Treating chronic pain requires much more than medications

STAT

There’s a lot of buzz surrounding the new non-addictive pain pill that is up for FDA approval. It works as well as opioids for treating acute pain, and shows promise in treating chronic neuropathic pain as well. We are constantly getting messages from patients we are treating for all different types of chronic pain — arthritis, back pain, fibromyalgia, and pain we just can’t seem to figure out — along the lines of “Doc, have you heard about it?

304
304
article thumbnail

Biogen, Ionis shelve ALS drug following study failure

BioPharma Dive

While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.

128
128
article thumbnail

STAT+: NVIDIA’s Kimberly Powell touts progress on AI in drug discovery

STAT

SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug? The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today. Kimberly Powell, vice president of healthcare for NVIDIA, pointed to an increase in investigational new drug applications filed with the Food and Drug Administration that

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Lilly’s once-weekly insulin matches daily shots in late-stage tests

BioPharma Dive

The results, which showed Lilly’s drug was as effective at controlling blood sugar as standard injections, come as Novo Nordisk seeks approval for a competing once-weekly insulin.

122
122
article thumbnail

STAT+: Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis

STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

315
315
article thumbnail

Health spending has grown less than planned, finds IFS report

The Pharmacist

Health spending has grown ‘by less than planned’ since the last general election, with cash top-ups ‘insufficient’ to offset inflation, a leading think tank has found. Plans set out in the 2019 election campaign indicated the DHSC budget would increase by 3.3% a year above inflation, however spending has risen by only 2.7% a year […] The post Health spending has grown less than planned, finds IFS report appeared first on The Pharmacist.

111
111
article thumbnail

STAT+: Lilly’s weekly insulin works as well as daily products, new studies show

STAT

Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal insulin products in two late-stage studies, paving the way for the drug to compete with a similar weekly insulin developed by Novo Nordisk. In a 52-week trial of type 2 diabetes patients using insulin for the first time, those on the weekly insulin, called efsitora alfa, had a 1.34% reduction in blood sugar levels, while people on the comparator daily insulin degludec, sold as Tresiba by Novo, had a 1.

Diabetes 295
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

PulmCrit: Why the new study associating piptazo with increased mortality is wrong

EMCrit Project

Piperacillin-tazobactam is an antibiotic that a lot of people love to hate. Combine this with the conservatism that often (rightfully) surrounds drug safety, and it creates a lot of volatility. Before going further, we should review some recent history regarding piptazo. In the early 2010's, a series of retrospective correlational studies found that patients treated […] EMCrit Project by Josh Farkas.

109
109
article thumbnail

STAT+: Biogen, Ionis drop ALS treatment after study failure

STAT

A plan to use new genetic techniques to treat non-genetic forms of ALS failed in an early study, Ionis and Biogen announced Thursday. The companies said they would discontinue the program. In the randomized, 99-person trial, the companies tested a drug designed to silence a gene called ATXN2. Over the last decade, numerous drugs have been built to silence genes in ALS patients, but most of them have, fittingly, focused on rare genetic forms of ALS, where neurons die largely because of the work o

295
295
article thumbnail

Women drinkers particularly at risk of developing heart disease

The Pharmacist

Women who consume eight or more alcoholic drinks a week are significantly more likely to develop heart disease than those who drink less, researchers have found. A US study of more than 430,000 adults with an average aged of 44 years and no heart disease at the start also found an increased risk in men […] The post Women drinkers particularly at risk of developing heart disease appeared first on The Pharmacist.

105
105
article thumbnail

Amid backlash to harm reduction, addiction experts warn against reprising ‘war on drugs’

STAT

SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians alike are fed up. Overdose death rates remain near all-time highs. The Tenderloin, a historic downtown neighborhood, remains rife with open-air substance use and drug dealing. Public health officials are increasingly at a loss. In recent years, much of the backlash has come to focus on harm reduction, the philosophy and practice of reducing the most acute drug-related harms without expecting ab

300
300
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

FT US Pharma and Biotech Summit: Live coverage

pharmaphorum

Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.

119
119
article thumbnail

STAT+: PDS Biotech’s survival benefit is absurdly overstated

STAT

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered every Thursday to their inbox. Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum.

303
303
article thumbnail

Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients

Pharma Times

The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK

139
139
article thumbnail

Second House panel advances two-year telehealth extension

STAT

WASHINGTON — A House subcommittee on Thursday advanced legislation that would extend some pandemic-era telehealth policies in Medicare for two years, bringing the panel’s approach in line with another committee. During the pandemic, Congress extended flexibilities that changed what kinds of care Medicare beneficiaries could receive over telehealth and where.

272
272
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Detailed trial data show Bayer drug alleviates menopause symptoms

BioPharma Dive

Full study results disclosed ahead of a medical meeting showed elinzanetant consistently reduced the frequency and severity of hot flashes.

122
122
article thumbnail

STAT+: Obesity drug from Roche succeeds in early test, sending company shares up

STAT

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.   The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said.

article thumbnail

Closed Loop and Pharmanovia investigate precision medicine combination in hypertension

Pharma Times

The OptiZest study aims to investigate a personalised dose of Zestril in these patients

141
141
article thumbnail

Listen: Live! From the STAT Breakthrough Summit West

STAT

On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

271
271
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Growth Guardian I Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies

Express Pharma

In this special edition of the Express Pharma-NutrifyToday Boardroom Series, we introduce you to Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies, one of the six Growth Guardians who will judge the merit of the contestants during the Nutrify C Suite Sumflex – Innovation Battlefield. As the Founder President of the Association of Herbal and Nutraceuticals Manufacturers of India (AHNMI), Mariwala has also gained quite a reputation as a mentor and angel inv

107
107
article thumbnail

Blackstone wants in on red-hot immunology market

STAT

The need-to-know this morning Biogen  and  Ionis Pharmaceuticals  are  ending their development  of an experimental drug for ALS based on results of a Phase 1/2 trial. Johnson & Johnson  said it will  acquire   Proteologix , a privately-held biotech focused on immune-mediated diseases, for $850 million with potential for additional milestone payments.

Immunity 262
article thumbnail

GSK pledges £45m to support global AMR prevention

European Pharmaceutical Review

GSK’s funding would be accessible for approved projects including those that employ new technology such as AI to improve interpretation and use complex scientific data” GSK is set to become the first founding partner of the Fleming Initiative. According to GSK, The Fleming Initiative’s will gather “world-class scientific, technology, policy and behavioural science expertise with clinical experience in a global network of centres to find, test, and scale solutions to [antimicrobial resistan

96
article thumbnail

STAT+: Pharmalittle: We’re reading about a Roche obesity drug, an experimental Lilly insulin, and more

STAT

Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus again. Our spirits remain sunny, however, because we recall a bit of insight from the Morning Mayor, who taught us that “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.

Diabetes 260
article thumbnail

12 Questions with Kirsten Parr

pharmaphorum

Get to know Kirsten Parr through 12 insightful questions as she shares her experiences and insights while working at IPG Health Medical Communications.